Tvardi Therapeutics, Inc.

TVRD

Tvardi Therapeutics, Inc.

TVRD

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2025-02-28Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:2,700,595Shares Outstanding:9,381,344Institutional Ownership Pct.:28.79%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	16	20	21	21	21	34	32	37	49	47	52	63
Debt Securities Available For Sale Excluding Accru…	-	-	-	-	-	-	-	5	7	23	49	16
Accounts Receivable Net Current	-	-	-	-	-	1	0	0	0	2	3	3
Inventory Net	-	-	-	-	-	1	1	1	2	3	3	3
Income Taxes Receivable	-	-	-	-	-	-	-	-	1	1	1	1
Other Receivables Net Current	-	-	-	-	-	1	4	1	1	1	1	2
Prepaid Expense Current	-	-	-	-	-	2	1	2	4	6	8	13
Restricted Cash Current	-	-	-	-	-	-	-	2	-	-	0	0
Short Term Investments	-	5	10	15	20	-	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	1	0	1	2	2	-	0	-	-	-	-	-
Assets Current	17	25	32	38	43	-	32	48	64	81	116	101
Property Plant And Equipment Net	0	0	0	0	0	-	0	3	3	4	3	1
Intangible Assets Net Excluding Goodwill	0	0	0	0	0	-	0	-	-	-	-	-
Operating Lease Right Of Use Asset	0	0	0	0	0	-	0	-	4	4	5	7
Debt Securities Available For Sale Excluding Accru…	-	-	-	-	-	-	-	-	-	-	-	5
Deferred Costs	-	-	-	-	-	-	3	-	-	-	-	-
Other Assets Noncurrent	0	0	0	0	0	-	0	-	-	-	-	-
Assets	18	26	32	39	44	39	35	51	72	90	126	115
Accounts Payable And Accrued Liabilities Current	-	-	-	-	-	1	4	7	14	15	26	22
Liabilities And Stockhold…
Restricted Cash Noncurrent	-	-	-	-	-	-	-	-	2	2	2	2
Liabilities Current
Royalty Guarantees Commitments Amount	-	-	-	-	-	46	44	41	40	38	37	-
Accounts Payable Current	5	5	3	4	2	-	2	-	-	-	-	-
Accrued Liabilities Current	4	7	8	7	8	-	8	-	-	-	-	-
Operating Lease Liability Current	0	0	0	0	0	-	0	3	0	0	-	0
Liabilities Current	9	11	11	11	11	1	10	10	14	15	26	23
Operating Lease Liability Noncurrent	0	0	0	0	0	-	0	-	7	7	6	7
Convertible Long Term Notes Payable	-	-	-	-	-	-	30	-	-	-	-	-
Liabilities	9	11	11	11	11	47	41	51	61	60	69	-
Temporary Equity Carrying Amount Attributable To P…	-	-	-	0	0	86	86	86	86	-	-	-
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	132	132	131	131	131	752	1	749	747	745	742	738
Accumulated Other Comprehensive Income Loss Net Of…	-	0	0	0	-0	-	-	-0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-124	-117	-110	-103	-98	-761	-92	-748	-735	-715	-685	-652
Stockholders Equity	8	15	21	28	33	-101	-91	-79	-73	30	57	86
Preferred Stock Shares Issued	-	-	-	-	-	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	-	-	-	-	-	0	0	0	0	0	0	0
Liabilities And Stockholders Equity	18	26	32	39	44	39	35	51	72	90	126	115
Preferred Stock Par Or Stated Value Per Share	-	-	-	-	-	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	-	-	-	-	-	5	5	5	5	5	5	5
Temporary Equity Par Or Stated Value Per Share	-	-	-	0.001	0.001	-	0.001	-	-	-	-	-
Temporary Equity Shares Authorized	-	-	0	0	0	-	30	-	-	-	-	-
Temporary Equity Shares Issued	-	-	0	0	0	4	4	4	4	-	-	-
Temporary Equity Shares Outstanding	-	-	0	0	0	-	4	-	-	-	-	-
Share Based Compensation …
Temporary Equity Liquidation Preference	-	-	0	0	0	-	86	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	150	150	150	150	150	17	58	200	200	100	8	100
Common Stock Shares Issued	9	9	9	9	9	2	3	5	5	5	5	5
Shares Outstanding	9	9	9	9	9	2	3	5	5	5	5	5
Share Based Compensation …

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-19.14%	-64.11%	-39.95%	-	-	-	-	-	-	-	-	-
2025	7.39%	-15.37%	-1.28%	30.77%	69.10%	-80.45%	1.70%	-0.73%	-3.41%	-2.52%	12.26%	-17.30%
2024	-16.80%	-62.00%	-53.87%	-2.13%	-16.11%	-9.73%	-18.90%	32.62%	22.97%	-6.34%	73.85%	84.33%
2023	-	-	-	-	-	-	5.93%	-48.05%	-51.36%	-8.08%	-30.91%	-32.22%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.87	2.25	2.86	3.48	4.04	-	3.06	4.77	4.59	5.38	4.54	4.40
Quick Ratio	1.73	2.22	2.79	3.30	3.84	-	2.92	4.47	4.20	4.82	4.11	3.70
Working Capital	7.96M	14.07M	20.50M	27.40M	32.45M	-	21.32M	37.87M	49.96M	66.13M	90.57M	77.72M
Leverage & Debt
Debt to Equity	1.09	0.78	0.53	0.40	0.33	-0.47	-0.45	-0.64	-0.83	2.02	1.20	0.27
Interest Coverage TTM	-	-316.61	-41.09	-7.29	-6.89	-5.01	-	-	-	-	-	-
Debt Ratio	0.52	0.44	0.35	0.29	0.25	-	1.16	0.99	0.84	0.67	0.55	0.20
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.08	0.09	0.11	-	0.09	0.10	0.11	0.14	0.14	0.13
Days Sales Outstanding TTM	-	-	-	-	-	71.04	81.11	79.55	11.92	37.02	52.44	57.63
Receivables Turnover TTM	-	-	-	-	-	5.14	4.50	4.59	30.63	9.86	6.96	6.33
Per Share Metrics
Diluted EPS TTM	-2.78	-1.65	-2.34	0.30	0.34	-3.21	-11.42	-29.33	-38.08	-80.82	-26.26	-25.79
Free Cash Flow Per Share TTM	-2.67	-2.31	-3.17	-2.42	-3.04	1.33	-7.84	-13.51	-18.68	-60.09	-20.93	-21.81
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	-	-	-	-	51.52%	51.44%	63.74%
Operating Profit Margin TTM	-	-	-1,041.18%	-117.92%	-68.13%	-36.92%	-393.82%	-864.96%	-894.43%	-729.19%	-579.43%	-566.29%
Net Profit Margin TTM	-	-	-708.99%	70.78%	43.50%	-109.36%	-411.90%	-869.46%	-891.60%	-723.49%	-565.21%	-548.95%
Growth Metrics
Net Revenue Growth (1Y)	-100.00%	-100.00%	-64.00%	-53.67%	-40.16%	-55.30%	-65.96%	-59.08%	-59.53%	-60.83%	-49.92%	-43.39%
Net Income Growth (1Y)	-1,010.66%	86.46%	-38.04%	-103.77%	-102.92%	-93.24%	-75.20%	-35.18%	-12.20%	45.21%	38.65%	31.63%
EPS Growth (1Y)	-900.50%	-48.81%	-78.50%	-101.04%	-100.91%	-96.02%	-56.52%	13.73%	53.40%	329.75%	37.33%	30.39%
Valuation Metrics
P/E TTM	-0.68	-1.93	-1.75	128.31	67.22	-4.73	-1.61	-0.38	-0.24	-0.41	-1.02	-2.35
P/B TTM	2.13	2.06	1.52	13.11	5.84	-0.39	-0.52	-0.36	-0.33	1.67	2.11	3.19
P/S TTM	-	-	12.42	90.81	29.24	5.17	6.62	3.29	2.17	2.93	5.76	12.87
Market Cap	17.82M	29.83M	31.90M	365.42M	192.39M	39.17M	47.26M	28.55M	23.91M	49.68M	120.70M	273.24M
Enterprise Value	2.06M	9.98M	11.17M	344.01M	171.74M	27.73M	45.91M	19.11M	7.81M	1.18M	67.02M	208.46M
Calculated Values
Free Cash Flow TTM	-25.03M	-21.67M	-23.50M	-22.65M	-25.05M	3.41M	-20.19M	-34.78M	-48.09M	-91.12M	-94.45M	-98.54M
Net Debt	-15.77M	-19.85M	-20.73M	-21.42M	-20.65M	-11.44M	-1.36M	-9.44M	-16.11M	-48.50M	-53.68M	-64.78M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-02-28Sale

Owner: Posner, Christopher

Title: PRESIDENT AND CEO

Shares: 583

Price/Share: $4.75

Value: $2,769.25

Shares Owned: 13,109

Relationship: Director,Officer

Ownership: Direct

2025-02-28Sale

Owner: Terrillion, Scott

Title: SEC'Y; CHIEF COMPLIANCE & G.C.

Shares: 163

Price/Share: $4.76

Value: $775.88

Shares Owned: 7,190

Relationship: Officer

Ownership: Direct

2025-02-04Sale

Owner: Posner, Christopher

Title: PRESIDENT AND CEO

Shares: 372

Price/Share: $4.72

Value: $1,755.84

Shares Owned: 13,692

Relationship: Director,Officer

Ownership: Direct

2024-11-04Sale

Owner: Posner, Christopher

Title: PRESIDENT AND CEO

Shares: 3,668

Price/Share: $0.29

Value: $1,063.72

Shares Owned: 168,768

Relationship: Director,Officer

Ownership: Direct

2024-08-01Sale

Owner: Posner, Christopher

Title: PRESIDENT AND CEO

Shares: 4,149

Price/Share: $0.35

Value: $1,452.15

Shares Owned: 172,436

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-02-28	Posner, Christopher	Director,Officer	PRESIDENT AND CEO	Direct	Sale	583	4.75	$2,769.25	13,109	4
2025-02-28	Terrillion, Scott	Officer	SEC'Y; CHIEF COMPLIANCE & G.C.	Direct	Sale	163	4.76	$775.88	7,190	4
2025-02-04	Posner, Christopher	Director,Officer	PRESIDENT AND CEO	Direct	Sale	372	4.72	$1,755.84	13,692	4
2024-11-04	Posner, Christopher	Director,Officer	PRESIDENT AND CEO	Direct	Sale	3,668	0.29	$1,063.72	168,768	4
2024-08-01	Posner, Christopher	Director,Officer	PRESIDENT AND CEO	Direct	Sale	4,149	0.35	$1,452.15	172,436	4
2024-05-02	Posner, Christopher	Director,Officer	PRESIDENT AND CEO	Direct	Sale	3,936	0.75	$2,952.00	176,585	4
2024-04-05	Goncalves, Joana	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	2,753	0.83	$2,284.99	53,365	4
2024-04-05	Terrillion, Scott	Officer	SEC'Y; CHIEF COMPLIANCE & G.C.	Direct	Sale	2,753	0.83	$2,284.99	88,247	4
2024-02-29	Posner, Christopher	Director,Officer	PRESIDENT AND CEO	Direct	Sale	5,834	0.89	$5,192.26	180,521	4
2024-02-29	Terrillion, Scott	Officer	SEC'Y; CHIEF COMPLIANCE & G.C.	Direct	Sale	3,293	0.89	$2,930.77	91,000	4
2024-02-29	Goncalves, Joana	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	3,293	0.89	$2,930.77	56,118	4
2024-02-08	Posner, Christopher	Director,Officer	PRESIDENT AND CEO	Direct	Sale	35,575	0.53	$18,854.75	186,355	4
2024-02-01	Posner, Christopher	Director,Officer	PRESIDENT AND CEO	Direct	Sale	4,981	0.55	$2,739.55	221,930	4
2023-11-02	Posner, Christopher	Director,Officer	President and CEO	Direct	Sale	3,796	1.22	$4,631.12	164,411	4
2023-08-03	Posner, Christopher	Director,Officer	President and CEO	Direct	Sale	4,307	3.07	$13,222.49	168,207	4
2023-06-23	Terrillion, Scott	Officer	Sec'y; Chief Compliance & G.C.	Direct	Sale	2,483	3.51	$8,715.33	88,563	4
2023-06-23	Goncalves, Joana	Officer	Chief Medical Officer	Direct	Sale	2,723	3.51	$9,557.73	53,681	4
2023-06-23	Menzaghi, Frederique Ph.D…	Officer	Chief Scientific Off,SVP-R&D	Direct	Sale	2,993	3.51	$10,505.43	153,747	4
2023-05-05	Posner, Christopher	Director,Officer	President and CEO	Direct	Sale	3,869	4.40	$17,023.60	172,514	4
2023-04-04	Menzaghi, Frederique Ph.D…	Officer	Chief Scientific Off,SVP-R&D	Direct	Sale	2,733	4.91	$13,419.03	156,740	4
2023-04-04	Goncalves, Joana	Officer	Chief Medical Officer	Direct	Sale	2,481	4.91	$12,181.71	56,404	4
2023-04-04	Terrillion, Scott	Officer	Sec'y; Chief Compliance & G.C.	Direct	Sale	2,481	4.91	$12,181.71	91,046	4
2023-03-03	Terrillion, Scott	Officer	Sec'y; Chief Compliance & G.C.	Direct	Sale	6,256	9.71	$60,745.76	93,527	4
2023-03-03	Menzaghi, Frederique Ph.D…	Officer	Chief Scientific Off,SVP-R&D	Direct	Sale	6,802	9.71	$66,047.42	159,473	4
2023-03-03	Goncalves, Joana	Officer	Chief Medical Officer	Direct	Sale	6,221	9.71	$60,405.91	58,885	4
2023-03-03	Posner, Christopher	Director,Officer	President and CEO	Direct	Sale	5,987	9.71	$58,133.77	176,383	4
2023-02-16	Goncalves, Joana	Officer	Chief Medical Officer	Direct	Sale	2,265	10.20	$23,103.00	65,106	4
2023-02-08	Maynard, Ryan D	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	5,488	0.53	$2,908.64	8,012	4
2023-02-08	Terrillion, Scott	Officer	SEC'Y; CHIEF COMPLIANCE & G.C.	Direct	Sale	7,770	0.53	$4,118.10	94,293	4
2023-02-08	Goncalves, Joana	Officer	CHIEF MEDICAL OFFICER	Direct	Sale	7,770	0.53	$4,118.10	59,411	4
2023-02-02	Posner, Christopher	Director,Officer	President and CEO	Direct	Sale	4,191	11.80	$49,453.80	182,370	4
2023-01-17	Goncalves, Joana	Officer	Chief Medical Officer	Direct	Sale	2,265	10.81	$24,484.65	67,371	4
2022-12-29	Goncalves, Joana	Officer	Chief Medical Officer	Direct	Sale	2,265	10.18	$23,057.70	69,636	4
2022-12-21	Goncalves, Joana	Officer	Chief Medical Officer	Direct	Sale	2,992	11.27	$33,719.84	71,901	4
2022-12-21	Terrillion, Scott	Officer	Sec'y; Chief Compliance & G.C.	Direct	Sale	2,561	11.27	$28,862.47	99,783	4
2022-12-21	Menzaghi, Frederique Ph.D…	Officer	Chief Scientific Off,SVP-R&D	Direct	Sale	3,506	11.27	$39,512.62	166,275	4
2022-11-16	Posner, Christopher	Director,Officer	President and CEO	Direct	Sale	14,470	11.13	$161,051.10	186,561	4
2022-09-14	Vogelbaum, Martin	Director	-	Direct	Sale	10,800	10.28	$111,024.00	44,988	4
2022-07-15	Ives, Jeffrey L.	Director	-	Direct	Sale	3,600	9.05	$32,580.00	15,476	4
2022-07-15	Bains, Harrison M Jr	Director	-	Direct	Sale	7,200	9.05	$65,160.00	25,076	4
2022-04-04	Posner, Christopher	Director,Officer	President and CEO	Direct	Sale	2,006	12.67	$25,416.02	201,031	4
2022-04-01	Menzaghi, Frederique Ph.D…	Officer	Chief Scientific Off,SVP-R&D	Direct	Sale	1,784	11.91	$21,247.44	169,781	4
2022-04-01	Terrillion, Scott	Officer	Sec'y; Chief Compliance & G.C.	Direct	Sale	1,642	11.91	$19,556.22	102,344	4
2022-04-01	Goncalves, Joana	Officer	Chief Medical Officer	Direct	Sale	1,642	11.91	$19,556.22	74,893	4
2022-03-03	Terrillion, Scott	Officer	Sec'y; Chief Compliance & G.C.	Direct	Sale	1,787	11.38	$20,336.06	103,986	4
2022-03-03	Reilly, Thomas Charles	Officer	Chief Financial Officer	Direct	Sale	2,044	11.38	$23,260.72	37,811	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

28.79%

Inst. Shares: 2,700,595

Shares Outstanding: 9,381,344

2025-12-31

37.92%

Inst. Shares: 2,813,363

Shares Outstanding: 7,419,060

2025-09-30

27.73%

Inst. Shares: 2,600,681

Shares Outstanding: 9,377,079

2025-06-30

23.20%

Inst. Shares: 1,913,173

Shares Outstanding: 8,246,582

2025-03-31

24.59%

Inst. Shares: 633,297

Shares Outstanding: 2,575,462

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	2,700,595	9,381,344	28.79%
2025-12-31	2,813,363	7,419,060	37.92%
2025-09-30	2,600,681	9,377,079	27.73%
2025-06-30	1,913,173	8,246,582	23.20%
2025-03-31	633,297	2,575,462	24.59%
2024-12-31	1,074,240	2,574,233	41.73%
2024-09-30	1,097,283	2,574,767	42.62%
2024-06-30	1,416,128	2,574,767	55.00%
2024-03-31	1,803,182	1,516,336	118.92%
2023-12-31	1,884,006	4,512,422	41.75%
2023-09-30	2,119,142	4,517,833	46.91%
2023-06-30	2,267,080	4,498,449	50.40%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Tvardi Therapeutics, Inc. (TVRD) — SEC Financial Statements & Analysis

Tvardi Therapeutics, Inc. (TVRD) is a pharmaceutical preparations company, incorporated in DE. Tvardi Therapeutics, Inc. trades on Nasdaq as: TVRD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Tvardi Therapeutics, Inc. reported a -100.00% year-over-year revenue growth, a Gross Profit Margin of 51.52% (TTM), a Debt-to-Equity ratio of 1.09x, a Price-to-Sales (P/S) ratio of 12.42x (TTM), a Price-to-Book (P/B) ratio of 2.13x (TTM), at a market cap of $17.82M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Gross Profit Margin TTM: 51.52%
Debt To Equity: 1.09x
P/S TTM: 12.42x
P/B TTM: 2.13x
Market Cap: $17.82M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Tvardi Therapeutics, Inc. in?

Tvardi Therapeutics, Inc. (TVRD) operates in the Pharmaceutical Preparations industry.

What is TVRD's market cap?

Tvardi Therapeutics, Inc. (TVRD) has a market capitalization of $17.82M as of 2026-06-30.

What exchange does TVRD trade on?

Tvardi Therapeutics, Inc. (TVRD) trades on the Nasdaq.

Where is Tvardi Therapeutics, Inc. incorporated?

Tvardi Therapeutics, Inc. is incorporated in DE.